Every dollar will be matched! Help fund the critical next phase of Islet Sheet research.
After years of research, we are close to realizing a dream for people with type 1: using the Islet Sheet to normalize blood sugar without immune suppression drugs. JDRF has recognized the promise of encapsulated islets and is funding tests of the Islet Sheet. But we need your help to speed this innovation to clinical trials. A generous donor will match every dollar up to $50,000!
June 14, 2013
This spring, Dr. Jonathan R. T. Lakey, a principal collaborator in the Islet Sheet Project, was awarded a major grant by JDRF (formerly the Juvenile Diabetes Research Foundation) to study... READ MORE
April 15, 2013
Over the weekend, Hanuman Medical Foundation received a very generous matching grant of $50,000 to encourage community-based funding for the Islet Sheet Project. This means Hanuman will begin an... READ MORE
There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.
The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.
“We believe this technology has significant potential to be considered a ‘cure’ for type 1 diabetes.”
—The authors of Targeting a Cure for Type 1 Diabetes
ASK AN EXPERT
Have a question about diabetes research, especially about islet transplantation? Looking for sound advice about managing type 1 diabetes? Interested in the work of our foundation? Ask here, and an expert from the Hanuman team will respond.
There already are several large foundations that focus on a cure for type 1 diabetes—for example, JDRF and DRI. Why create another nonprofit foundation that can only siphon off some of the scarce contributions for very expensive research?
That’s a key question, Michael. Hanuman Medical Foundation was created to fund essential research to test a particular modality of therapy for type 1 diabetes: the use of an alginate sheet to encapsulate living islet cells, implanted in patients with... READ MORE
Watch a clip from the documentary film The Human Trial of Scott King describing how he was diagnosed with type 1. Learn more about the film.
This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments.
June 13th, 2013
A year ago our only collaborator was Jonathan Lakey at UCI. This has changed a lot recently. Thanks to growing interest in the need for encapsulation to protect islets made from human stem cells, and through contacts made through the JDRF/Helmsley Encapsulation Consortium, the number of collaborators for Islet Sheet research has gone up 500%... READ MORE
June 8th, 2013
We are ready for the crucial animal study to push the Islet Sheet into clinical trials. The definitive model is the pancreatectomized dog, which is reliably diabetic, well-understood, and will accurately predict the safety and efficacy of the Islet Sheet in humans with type 1 diabetes. In the discussion of my previous post, I was... READ MORE
Animated views of how the Islet Sheet with its encapsulated islets works
Tweets by @ScottRobertKing